News & Insights
Avec® securely connects disparate clinical trial and health data among clinical research networks—accelerating discover
In the fourth video in our series we talk about what drives our work each day: the human impact of Avec®. In the HIT industry, it’s easy to hone in on the large amounts of disparate data in need of integration and lose sight of its origin. But at Signet Accel, true interoperability is about more than code. Every piece of data represents a friend, loved one, family member or a colleague in need of or receiving care.
By Kimberley Ferguson, Executive Vice President, Sales & Marketing
Will we be asking our doctors for Watson by name? IBM is counting on it.
By John Raden, Chief Executive Officer
Are confidentiality, privacy, security and sharing incompatible goals?
Avec® creators Dr. Philip Payne and Dr. Peter Embi discuss true interoperability in the second video of our four-part series exploring precision medicine, our unique approach to solving the interoperability problem, and the human impact of Avec®.
Alliance provides unprecedented speed and accuracy to big data integration and discovery in healthcare industry.